Biocon CEO Siddharth Mittal outlines the company's strategy in the competitive GLP-1 market. Focusing on liraglutide's launch in the US and Europe, he highlights opportunities in emerging markets. While semaglutide is a longer-term play, Biocon is actively filing for approvals, anticipating launches in 2027.
Indian IT stocks experienced a significant downturn due to AI concerns, with the Nifty IT index falling 21% in February. However, 25 select stocks defied the slump, showing positive returns by focusing on AI infrastructure, integration, and specialized engineering, indicating potential future growth themes for the sector.
In the Nifty500 pack, 13 stocks' closing prices crossed above their 200 DMA (Daily Moving Averages) on February 25, 2026, according to stockedge.com's technical scan data. The 200-day daily moving average (DMA) is used by traders as a key indicator for determining the overall trend in a particular stock. As long as the stock is priced above the 200-day SMA on the daily timeframe, it is generally considered to be in an overall uptrend. Take a look:
Wall Street indexes climbed to two-week highs, led by tech stocks, as optimism about AI's potential benefits overshadowed concerns about disruption and costs. Nvidia's strong earnings fueled the rally, with the Nasdaq showing the largest percentage gain. Investors are weighing existential AI risks against potential returns.
Asian markets are rising for the fourth day. Concerns about artificial intelligence are easing. Nvidia's sales forecast is upbeat. This is boosting Asian chipmakers. South Korea's Kospi Index reached a record high. The dollar weakened. Gold edged up. Bitcoin fell. Investors are watching Nvidia's outlook to support the AI trade.
US imposition of a 125.87% countervailing duty on Indian solar modules is set to impact domestic companies by potentially lowering module prices. Exporters may redirect unsold inventory to India, while companies like Waaree Energies are strengthening US manufacturing to mitigate the effects. The duty erodes future revenue visibility for Indian manufacturers targeting the US market.
Shapoorji Pallonji Group is set to raise approximately 25,000 crore through a bond issue. This fundraising effort, planned for early April, is expected to have a lower pricing than previous borrowings. Improved prospects for asset sales and a potential settlement regarding its stake in Tata Sons are boosting investor confidence.
